Stockreport

Here's What the Wall Street Thinks About Nuvation Bio Inc. (NUVB) [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF a Buy rating on the stock and raised the price target from $10 to $12. Earlier, on January 13, Gregory Renza from Truist Financial also reiterated a Buy rating on Nuvati [Read more]